Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $56,671 | 18 | 78.4% |
| Travel and Lodging | $6,935 | 20 | 9.6% |
| Food and Beverage | $3,974 | 18 | 5.5% |
| Honoraria | $3,600 | 2 | 5.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,100 | 1 | 1.5% |
| Education | $43.17 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sarepta Therapeutics, Inc. | $35,956 | 24 | $0 (2024) |
| Strongbridge US INC. | $12,481 | 20 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $6,496 | 3 | $0 (2023) |
| Vertex Pharmaceuticals Incorporated | $5,871 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,436 | 3 | $0 (2023) |
| GENZYME CORPORATION | $3,355 | 1 | $0 (2023) |
| Lupin Inc. | $2,368 | 1 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $2,295 | 2 | $0 (2023) |
| Biogen, Inc. | $64.64 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,330 | 1 | Sarepta Therapeutics, Inc. ($1,330) |
| 2023 | $31,900 | 20 | Sarepta Therapeutics, Inc. ($14,061) |
| 2022 | $2,650 | 1 | Sarepta Therapeutics, Inc. ($2,650) |
| 2021 | $5,143 | 3 | Sarepta Therapeutics, Inc. ($4,200) |
| 2020 | $5,368 | 2 | Sarepta Therapeutics, Inc. ($3,000) |
| 2019 | $13,450 | 13 | Sarepta Therapeutics, Inc. ($10,715) |
| 2018 | $5,216 | 6 | Strongbridge US INC. ($5,216) |
| 2017 | $7,265 | 14 | Strongbridge US INC. ($7,265) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,330.00 | General |
| 11/10/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $57.00 | General |
| 11/10/2023 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $24.00 | General |
| 10/31/2023 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,300.00 | General |
| 10/30/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,355.00 | General |
| 10/01/2023 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $839.04 | General |
| 10/01/2023 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $535.40 | General |
| 10/01/2023 | Sarepta Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $350.00 | General |
| 10/01/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $118.73 | General |
| 10/01/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $40.80 | General |
| 10/01/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $40.80 | General |
| 08/04/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $2,257.50 | General |
| 04/19/2023 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $5,840.00 | General |
| 04/19/2023 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | Cash or cash equivalent | $517.80 | General |
| 04/19/2023 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | Cash or cash equivalent | $138.41 | General |
| 03/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 03/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $281.57 | General |
| 03/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | Cash or cash equivalent | $34.29 | General |
| 03/02/2023 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,755.00 | General |
| 02/24/2023 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,377.00 | General |
| 02/24/2023 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $918.00 | General |
| 06/16/2022 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 09/02/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 08/02/2021 | Sarepta Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 08/02/2021 | Biogen, Inc. | ADUHELM (Biological) | Education | In-kind items and services | $43.17 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 72 | 81 | $16,363 | $3,326 |
| 2022 | 3 | 56 | 91 | $20,110 | $4,919 |
| 2021 | 5 | 95 | 104 | $23,484 | $4,199 |
| 2020 | 5 | 78 | 99 | $18,489 | $3,809 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 47 | $9,551 | $1,877 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 15 | $4,495 | $953.28 | 21.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $2,317 | $495.72 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 41 | $8,282 | $2,295 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 37 | $7,437 | $1,704 | 22.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 13 | 13 | $4,391 | $919.92 | 21.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 32 | $6,432 | $1,460 | 22.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 33 | 33 | $7,952 | $1,145 | 14.4% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 14 | 14 | $4,592 | $766.48 | 16.7% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2021 | 12 | 12 | $3,312 | $647.04 | 19.5% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 11 | 13 | $1,196 | $180.22 | 15.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 27 | $5,358 | $1,584 | 29.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 18 | 18 | $4,189 | $638.76 | 15.2% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2020 | 11 | 11 | $2,973 | $611.19 | 20.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 25 | 32 | $3,800 | $600.59 | 15.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $2,169 | $374.49 | 17.3% |
About Dr. Nicholas Johnson, MD
Dr. Nicholas Johnson, MD is a Neurology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497969943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Johnson, MD has received a total of $72,322 in payments from pharmaceutical and medical device companies, with $1,330 received in 2024. These payments were reported across 60 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($56,671).
As a Medicare-enrolled provider, Johnson has provided services to 301 Medicare beneficiaries, totaling 375 services with total Medicare billing of $16,253. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Salt Lake City, UT
- Active Since 05/10/2007
- Last Updated 11/27/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1497969943
Products in Payments
- Exondys 51 (Drug) $13,715
- KEVEYIS (Drug) $12,481
- ADUHELM (Biological) $43.17
- SPINRAZA (Biological) $21.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Salt Lake City
Dr. Timothy West, Md, MD
Neurology — Payments: $1.0M
Stacey Steeves, Md, MD
Neurology — Payments: $735,535
Dr. John Foley, M.d, M.D
Neurology — Payments: $345,032
Dr. Amir Arain, Md, MD
Neurology — Payments: $288,901
Mark Bromberg, M.d.,Ph.d, M.D.,PH.D
Neurology — Payments: $252,027
Lucy Dewitt, Md, MD
Neurology — Payments: $126,769